Literature DB >> 19261370

Effect of the removal of the Fallopian tube during hysterectomy on ovarian survival: the orphan ovary syndrome.

Istvan Repasy1, Viktor Lendvai, Agnes Koppan, Jozsef Bodis, Miklos Koppan.   

Abstract

OBJECTIVE: The objective was to assess the long-term impact on ovarian survival of removing the Fallopian tube during hysterectomy. STUDY
DESIGN: We modified our standard operative policy by adding the option of removing the Fallopian tube, thus leaving an "orphan" ovary behind. In a follow-up study, we identified 82 patients who had undergone hysterectomy followed by a second operation for an adnexal condition. In 45 there was presence and in 37 there was absence of the Fallopian tube. Data analysis included the time interval between hysterectomy and the occurrence of adnexa-related complaints; diagnoses prior to and the type of the second surgery; histological diagnosis after and the success rate of the second surgery. For statistical analysis, Kruskal-Wallis One-Way ANOVA on Ranks and the Mann-Whitney Rank Sum Test were used.
RESULTS: In 35.5% of patients with an intact Fallopian tube, hydrosalpinx developed. Cystic degeneration of orphan ovaries occurred significantly earlier than that of the "regular" adnexae group (50.0 months vs. 84.2 months, p=0.031). Laparotomy and laparoscopy for second surgery showed equal success rates.
CONCLUSION: Removal of the Fallopian tube at abdominal hysterectomy decreases the incidence of the development of pelvic masses later, but causes earlier cystic degeneration of the remaining ovaries.

Entities:  

Mesh:

Year:  2009        PMID: 19261370     DOI: 10.1016/j.ejogrb.2008.12.019

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  8 in total

1.  Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition.

Authors:  Gery Lamblin; Capucine Meysonnier; Stéphanie Moret; Béatrice Nadaud; Georges Mellier; Gautier Chene
Journal:  Int Urogynecol J       Date:  2017-07-13       Impact factor: 2.894

2.  Should Fallopian Tubes Be Removed During Hysterectomy Procedures? - A Statement by AGO Ovar.

Authors:  M Pölcher; S Hauptmann; C Fotopoulou; B Schmalfeldt; I Meinhold-Heerlein; A Mustea; I Runnebaum; J Sehouli
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

3.  Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate.

Authors:  J Vorwergk; M P Radosa; K Nicolaus; N Baus; J Jimenez Cruz; M Rengsberger; M Gajda; H Diebolder; I B Runnebaum
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-27       Impact factor: 4.553

4.  Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010.

Authors:  Rikke Guldberg; Sonja Wehberg; Charlotte Wessel Skovlund; Ole Mogensen; Ojvind Lidegaard
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

5.  Ovarian cancer risk reduction through opportunistic salpingectomy.

Authors:  Janice S Kwon
Journal:  J Gynecol Oncol       Date:  2015-04       Impact factor: 4.401

Review 6.  Opportunistic salpingectomy for ovarian cancer prevention.

Authors:  Gillian E Hanley; Jessica N McAlpine; Janice S Kwon; Gillian Mitchell
Journal:  Gynecol Oncol Res Pract       Date:  2015-09-17

7.  Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy: Assessment of Possible Complications and Histopathological p53-Signatures.

Authors:  Gautier Chene; Sarah Urvoas; Stéphanie Moret; Béatrice Nadaud; Annie Buenerd; Philippe Chabert; Georges Mellier; Gery Lamblin
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-06-25       Impact factor: 2.915

8.  Ruptured ectopic pregnancy after hysterectomy with copper intrauterine device in place: A case report.

Authors:  Katie Pivarnik; Humera Syeda
Journal:  Case Rep Womens Health       Date:  2020-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.